Czech National Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.1M Buy
423,074
+19,180
+5% +$1.04M 0.1% 187
2026
Q1
$25.3M Buy
403,894
+12,997
+3% +$1.04M 0.17% 112
2025
Q4
$37.3M Buy
390,897
+14,563
+4% +$1.43M 0.24% 79
2025
Q3
$36.7M Buy
376,334
+14,705
+4% +$1.52M 0.25% 78
2025
Q2
$38.8M Buy
361,629
+23,011
+7% +$2.33M 0.3% 60
2025
Q1
$34.2M Buy
338,618
+19,290
+6% +$1.94M 0.31% 61
2024
Q4
$28.5M Buy
319,328
+19,339
+6% +$1.7M 0.26% 73
2024
Q3
$25.1M Buy
299,989
+19,833
+7% +$1.56M 0.25% 74
2024
Q2
$21.6M Buy
280,156
+22,391
+9% +$1.64M 0.25% 79
2024
Q1
$17.7M Buy
257,765
+1,316
+0.5% +$84.6K 0.23% 95
2023
Q4
$14.8M Buy
256,449
+533
+0.2% +$28.5K 0.21% 103
2023
Q3
$13.5M Buy
255,916
+85,706
+50% +$4.49M 0.22% 99
2023
Q2
$9.21M Buy
170,210
+1,440
+0.9% +$75.2K 0.21% 100
2023
Q1
$8.44M Buy
168,770
+1,043
+0.6% +$49.2K 0.21% 104
2022
Q4
$7.76M Buy
167,727
+1,353
+0.8% +$58.6K 0.21% 108
2022
Q3
$6.44M Buy
+166,374
New +$6.67M 0.18% 118

Other funds holding BSX

Czech National Bank's BSX Position: Q2 2026 in Review

Czech National Bank increased its Boston Scientific (BSX) stake by 4.7% in Q2 2026, buying an estimated $1.04M and bringing the position to 423,074 shares worth $18.1M. The position accounts for 0.1% of the portfolio, ranked #187.

Czech National Bank first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $38.8M in Q2 2025. 425 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Czech National Bank held 423,074 shares of Boston Scientific worth $18.1M as of Q2 2026.
  • Czech National Bank bought 19,180 Boston Scientific shares in Q2 2026, an estimated $1.04M.
  • Boston Scientific made up 0.1% of Czech National Bank's portfolio in Q2 2026, its #187 holding.
  • Czech National Bank first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's Boston Scientific position peaked at $38.8M in Q2 2025.
  • 425 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.